News UK court overturns AbbVie Humira patents Decision paves way for cheaper competitor in autumn 2018.
News Lilly’s RA drug Olumiant gains first approval in Europe Oral treatment could take the lead among next generation RA drugs
News Sanofi's Kevzara gains first approval in Canada Sanofi and Regeneron's new rheumatoid arthritis (RA) drug Kevzara has gained its first global approval in Canada.
News Delinia adds to Celgene's immunology ambitions Celgene continues with focus on autoimmune diseases.
News Amgen's Humira biosimilar first to gain EU nod But patents could delay launch for more than a year.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.